2015

As the controversy over drug pricing continues to heat up, Senators Chuck Grassley and John McCain have started to place…

As 2015 comes to a close for the FDA, it remains an agency in transition. The agency should soon see a new commissioner…

Senate Finance Committee Ranking Minority Member Ron Wyden and Republican member Charles Grassley released the results…

  As with any large piece of legislation, the Sunshine Act (Open Payments) has conjured up a wide variety of reactions, including…

We have previously written about the proposed Novartis AG settlement relating its False Claims Act suit. The suit…

We previously wrote about the actions Congress is taking to "combat rising prescription drug prices," and the rhetoric…

Despite Congressional interest in delaying Stage 3 of the electronic health record Meaningful Use program and the AMA…

Background The House Energy & Commerce Committee's Health Subcommittee held a hearing on November 17, 2015, to discuss a…

As our readers know, from both their own experience and the articles written on our website, drug pricing is a hot issue right…

The Senate Finance Committee has been conducting an investigation into Physician Owned Distributorships (PODs), leading…